GlaxoSmithKline invests $360 mln in post-Brexit UK manufacturing

LONDON, July 27 (Reuters) - GlaxoSmithKline plans

275 million pounds ($361 million) of new investments at three

drug manufacturing sites in Britain, signalling its confidence

in the country despite last month's vote to leave the European

Union.

(Reporting by Ben Hirschler; Editing by David Holmes)

Read more